Improving the care of Lassa fever patients: re-evaluating the use of Ribavirin and characterising cardiovascular function
<p>Lassa fever is a viral haemorrhagic fever, endemic to several West African countries. Case fatality rates average 30% across the literature. Ribavirin, a broad-spectrum antiviral agent, has been used to treat Lassa fever for four decades. Ribavirin is a pro-drug, metabolised to its active m...
Үндсэн зохиолч: | Salam, A |
---|---|
Бусад зохиолчид: | Horby, P |
Формат: | Дипломын ажил |
Хэл сонгох: | English |
Хэвлэсэн: |
2024
|
Нөхцлүүд: |
Ижил төстэй зүйлс
Ижил төстэй зүйлс
-
Two Cases of Lassa Fever Successfully Treated with Ribavirin and Adjunct Dexamethasone for Concomitant Infections
-н: Sylvanus Okogbenin, зэрэг
Хэвлэсэн: (2022-10-01) -
Ribavirin for Lassa Fever Postexposure Prophylaxis
-н: Christiane M. Hadi, зэрэг
Хэвлэсэн: (2010-12-01) -
Animal Models of Lassa Fever
-н: Rachel A. Sattler, зэрэг
Хэвлэсэн: (2020-03-01) -
Addressing bottlenecks in Lassa fever treatment: overcoming the ribavirin parenteral formulation challenge
-н: Qudus Olajide Lawal, зэрэг
Хэвлэсэн: (2024-07-01) -
Bibliometric analysis of global Lassa fever research (1970–2017): a 47 – year study
-н: Henshaw Uchechi Okoroiwu, зэрэг
Хэвлэсэн: (2018-12-01)